Meanwhile GeneMaster Lifesciences, which was set up in 2000, has developed a meningitis chip. The company's researchers selected 30 common pathogenic bacteria to use for probes, such as meningococcus, Streptococcus aureus and Escherichia. The chip, which can identify suspicious pathogens within 24 hours, is in the final stages of clinical trials.
去年創立的晶公司則研發出腦膜炎晶片，選定三十種常見的致病細菌作為探針，如腦膜炎雙球菌、金黃色鏈球菌、大腸桿菌等，能在二十四小時內鑑定可疑病菌，已進入臨床測試的最後階段。